We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




XIO Group Buys Laser Manufacturer Lumenis

By HospiMedica International staff writers
Posted on 01 Jul 2015
Print article
Lumenis (Yokneam, Israel) has signed a definitive agreement to be acquired by XIO Group (Hong Kong, China) for approximately USD 510 million.

Lumenis is currently the world's largest energy-based medical device manufacturer of surgical, ophthalmology, and aesthetic applications, provides devices that use energy-based technologies including laser, intense pulsed light (IPL), and radio-frequency (RF) technologies. The company has an active installed worldwide base of more than 80,000 systems, and a commercial presence in over 100 countries.

The XIO investment fund, with executive offices Hong Kong and offices in London and Shanghai, made the offer a little over a year since the medical company went public on NASDAQ, after a ten year hiatus since being delisted in 2005. The boards of directors of both companies have approved the transaction, which is expected to close in September 2015.The largest shareholders of Lumenis, Viola Group and XT Hi-Tech Investments (which collectively own approximately 59% of the shares), have entered into a customary voting agreement with XIO Group.

“Over the past three years we have managed to transform Lumenis into a strong, growing, and profitable company. We have refocused our strategy, introduced new products, and tripled our EBITDA,” said Tzipi Ozer-Armon, CEO of Lumenis. “Furthermore, we have created a very bright and promising future for Lumenis by building a robust pipeline of innovative products, a strong sales team in each region, and by enhancing our global brand recognition.”

“We are excited about the announced transaction and the value created for Lumenis' shareholders,” said Harel Beit-On, chairman of the board of directors of Lumenis. “Over the last years, we had an opportunity to lead Lumenis through a strategic transformation into a valuable growing business with global appeal. We respect and appreciate the efforts of Lumenis management and employees and wish the company continued success.”

Chinese companies have made recent large investments in Israeli companies in both high-tech and other industries. The most prominent transaction was the acquisition of Tnuva, Israel's largest dairy company, by Bright Food, and some 30 Chinese investors have invested in about 80 startups.

Related Links:

Lumenis
XIO Group


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Glassware Washer
Tiva 10-1VL

Print article

Channels

Surgical Techniques

view channel
Image: Lightning Flash 2.0 features advanced computer assisted vacuum thrombectomy software (Photo courtesy of Penumbra)

Next-Gen Computer Assisted Vacuum Thrombectomy Technology Rapidly Removes Blood Clots

Pulmonary embolism (PE) occurs when a blood clot blocks one of the arteries in the lungs. Often, these clots originate from the leg or another part of the body, a condition known as deep vein thrombosis,... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.